AU3266197A - Transdermic systems containing 2 active ingredients in separate compartments, their preparation process and their use as medicaments - Google Patents

Transdermic systems containing 2 active ingredients in separate compartments, their preparation process and their use as medicaments

Info

Publication number
AU3266197A
AU3266197A AU32661/97A AU3266197A AU3266197A AU 3266197 A AU3266197 A AU 3266197A AU 32661/97 A AU32661/97 A AU 32661/97A AU 3266197 A AU3266197 A AU 3266197A AU 3266197 A AU3266197 A AU 3266197A
Authority
AU
Australia
Prior art keywords
medicaments
active ingredients
preparation process
systems containing
separate compartments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU32661/97A
Other versions
AU739141B2 (en
Inventor
Jean-Luc Dubois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of AU3266197A publication Critical patent/AU3266197A/en
Application granted granted Critical
Publication of AU739141B2 publication Critical patent/AU739141B2/en
Assigned to AVENTIS PHARMA S.A. reassignment AVENTIS PHARMA S.A. Alteration of Name(s) in Register under S187 Assignors: HOECHST MARION ROUSSEL
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
AU32661/97A 1996-06-11 1997-06-10 Transdermic systems containing 2 active ingredients in separate compartments, their preparation process and their use as medicaments Ceased AU739141B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR96/07209 1996-06-11
FR9607209A FR2749514B1 (en) 1996-06-11 1996-06-11 TRANSDERMAL SYSTEMS CONTAINING 2 ACTIVE INGREDIENTS IN SEPARATE COMPARTMENTS, THEIR PREPARATION METHOD AND THEIR APPLICATION AS A MEDICAMENT
PCT/FR1997/001024 WO1997047305A1 (en) 1996-06-11 1997-06-10 Transdermal systems containing two active principles in separate compartments, their method of preparation and application as medicine

Publications (2)

Publication Number Publication Date
AU3266197A true AU3266197A (en) 1998-01-07
AU739141B2 AU739141B2 (en) 2001-10-04

Family

ID=9492920

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32661/97A Ceased AU739141B2 (en) 1996-06-11 1997-06-10 Transdermic systems containing 2 active ingredients in separate compartments, their preparation process and their use as medicaments

Country Status (19)

Country Link
EP (1) EP0904086B1 (en)
JP (1) JP2000511921A (en)
CN (1) CN1119150C (en)
AR (1) AR008229A1 (en)
AT (1) ATE284215T1 (en)
AU (1) AU739141B2 (en)
BR (1) BR9715082A (en)
CA (1) CA2257913A1 (en)
CZ (1) CZ295350B6 (en)
DE (1) DE69731883T2 (en)
ES (1) ES2235236T3 (en)
FR (1) FR2749514B1 (en)
NO (1) NO320999B1 (en)
PL (1) PL189361B1 (en)
RU (1) RU2209090C2 (en)
TR (1) TR199802577T2 (en)
TW (1) TWI228999B (en)
WO (1) WO1997047305A1 (en)
ZA (1) ZA975160B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306196A (en) * 2002-04-03 2003-11-16 Wyeth Corp Hormone replacement therapy
DE10220230A1 (en) * 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Use of Rotigotine to treat restless leg syndrome
WO2006041907A2 (en) 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Transdermal delivery of estradiol
DE102005034498A1 (en) * 2005-07-20 2007-01-25 Grünenthal GmbH Oral contraception with Trimegeston
EP1971325A2 (en) 2005-12-27 2008-09-24 Duramed Pharmaceuticals, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
US8491927B2 (en) * 2009-12-02 2013-07-23 Nimble Epitech, Llc Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
US10821297B2 (en) * 2016-09-30 2020-11-03 Johnson & Johnson Consumer Inc. Kit and method for topical delivery of benefits
JP6982960B2 (en) * 2017-02-07 2021-12-17 リンテック株式会社 Packaging and packaging

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430953A1 (en) * 1978-07-13 1980-02-08 Roussel Uclaf NOVEL 3,20-DIOXO 4,9-DIENE 21-HYDROXYL DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
DE3714140A1 (en) * 1987-04-28 1988-11-10 Lohmann Therapie Syst Lts ACTIVE SUBSTANCE PLASTER FOR THE CONTROLLED ADMINISTRATION OF ACTIVE SUBSTANCES TO THE SKIN, ITS USE AND METHOD FOR THE CONTROLLED ADMINISTRATION OF ACTIVE SUBSTANCES TO THE SKIN
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
DE4227989A1 (en) * 1992-08-21 1994-06-09 Schering Ag Agent for transdermal application containing 3-keto-desogestrel

Also Published As

Publication number Publication date
ES2235236T3 (en) 2005-07-01
NO320999B1 (en) 2006-02-27
DE69731883T2 (en) 2005-12-22
JP2000511921A (en) 2000-09-12
DE69731883D1 (en) 2005-01-13
FR2749514A1 (en) 1997-12-12
TR199802577T2 (en) 1999-03-22
CZ295350B6 (en) 2005-07-13
PL330597A1 (en) 1999-05-24
CN1119150C (en) 2003-08-27
NO985807D0 (en) 1998-12-11
AR008229A1 (en) 1999-12-29
EP0904086B1 (en) 2004-12-08
CA2257913A1 (en) 1997-12-18
TWI228999B (en) 2005-03-11
EP0904086A1 (en) 1999-03-31
BR9715082A (en) 2003-07-15
ATE284215T1 (en) 2004-12-15
RU2209090C2 (en) 2003-07-27
ZA975160B (en) 1998-06-11
FR2749514B1 (en) 1998-08-07
CN1227492A (en) 1999-09-01
WO1997047305A1 (en) 1997-12-18
PL189361B1 (en) 2005-07-29
NO985807L (en) 1999-02-10
CZ410898A3 (en) 1999-09-15
AU739141B2 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
HU0301171D0 (en) Antifungal active ingredients, pharmaceutical compositions containing the same and process for their preparation
HUP9903613A3 (en) Improvement in the taste of active pharmaceutical ingredients
CA2154424A1 (en) 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect
AU8170994A (en) Phospholipids as a vector for an active molecule, their preparation and their use in cosmetic or dermatological compositions
IL113389A0 (en) 1,4-Benzodiazepine compounds, pharmaceutical compositions containing them, their preparation and use
EP0687467A3 (en) Cosmetic and dermatological combinations containing glycerylalkylethers as active ingredients
SI0825178T1 (en) Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or in diagnostic agents and drugs containing them
EP0960885A4 (en) Depsipeptides and drugs containing the same as the active ingredient
AU3266197A (en) Transdermic systems containing 2 active ingredients in separate compartments, their preparation process and their use as medicaments
IL117067A (en) Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz¬b,f¾oxepines their preparation and pharmaceutical compositions containing them
IL117943A (en) Dihalopropene compounds and insecticides containing them as active ingredients
IL121969A0 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]-pentadecanone derivatives their preparation and pharmaceutical compositions containing them
IL108624A0 (en) Pseudopeptides, their preparation and pharmaceutical compositions containing them
AU5650894A (en) Tachyquinine antagonists, their preparation and use in pharmaceutical formulations
AU3011095A (en) 2,3-bridged 1,4-dihydropyridines, processes for their preparation and their use as medicaments
HUP9600665A3 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
HUP9802345A3 (en) Pyrazol-4-yl-benzoyl derivatives, preparation and use thereof, herbicide compositions containing these compounds as active ingredients
ZA961983B (en) Bicyclic compounds, preparation thereof and use in pharmaceutical compositions.
IL121407A0 (en) Substituted indanylidineacetylguanidines process for their preparation their use as medicaments or in diagnosis and medicaments containing them
AU1219092A (en) Substituted 2', 3'-dideoxy-5-trifluoromethyluridines, processes for their preparation and their use in medicaments
HUP9701205A3 (en) Fungicide composition containing two triazole-derivatives as active ingredients and use thereof
IL124415A (en) N, n'-bridged bisindolylmaleimides, their preparation and pharmaceutical compositions containing them
IL127503A (en) Transdermic systems containing two active ingredients in separate compartments, their preparation process and their use as medicaments

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: AVENTIS PHARMA S.A.

Free format text: FORMER OWNER WAS: HOECHST MARION ROUSSEL